News | Bened Biomedical Co., Ltd.

In the News

Bened Biomedical Affiliates US Distributor, Now Bened Life

Bened Biomedical Co, LTD., the global leader in psychobiotics with clinical studies, has acquired its US distributor Oryx Biomedical,...

Bened Biomedical Completes $10M Series A, Set for Expansion into US Healthcare Market

Medical probiotic leader Bened Biomedical Co., Ltd., which develops and markets neuroactive probiotic products, announced a completed...

Psychobiotics show promising avenue for mood support and beyond

By Danielle Masterson Emerging research suggests mental health and gut biology are intrinsically linked, presenting new opportunities in...

Psychobiotic PS128 Registration, Health Claims Approved in Thailand, Canada

TAIPEI, April 6, 2022 /PRNewswire/ -- Bened Biomedical announced recent approval of the company's probiotic L. plantarum PS128 in...

PS128 may reduce ADHD symptoms in children with Tourette's

22-OCT-2021 A new study analyzing the impact of probiotic PS128 on the symptoms of children with Tourette syndrome has concluded that...

Effects of PS128 on Depressive Symptoms and Sleep Quality

26-AUG-2021 A study involving 40 insomniacs has found that daily administration of the probiotic Lactobacillus plantarum PS128 can reduce...

Combined oxytocin and psychobiotic therapy improves autism symptoms in novel clinical study

TAIPEI, June 15, 2021 /PRNewswire/ A combination of oxytocin and a probiotic could synergistically improve symptoms of autism. These were...

Psychobiotic PS128 improves mood and sleep quality in its first clinical study on anxiety and stress

Bened Biomedical’s psychobiotic PS128 significantly improved insomnia, stress, and anxiety during a recent clinical trial. Participants...

Psychobiotic PS128 consumption shows benefits to Parkinson's symptoms in new clinical study

TAIPEI, Feb. 18, 2021 /PRNewswire/ -- Bened Biomedical, a leading Taiwanese probiotic company, has announced a successful clinical study...

Patented psychobiotic Lactobacillus plantarum PS128™ is now Self-affirmed GRAS

Bened Biomedical Co. Ltd., a global leader of functional probiotics esp. psycho-biotics and REJMIUS, INC. proudly announce the newest Self-a

Bened CEO Frankie Cheng Wins AABI Torch Best Entrepreneur Award

Bened Biomedical Grants Exclusive Rights for PS128™ to M8 Pharmaceuticals

Its portfolio companies address the most compelling trends in global health. The firm is currently investing out of its sixth fund.

Blackmores inks deal with psychobiotic supplier Bened

Bened has sealed a deal with the Blackmores Group to supply its proprietary probiotic strain PS128.

EU firm BeoPanax selected as exclusive psychobiotic product distributor

EU firm Beopanax selected as exclusive psychobiotic product distributor

Bened increases reach in Asia and Europe with new study

Psyched for psychobiotics: Bened increases reach in Asia and Europe with new study and proprietary strain

Pharmaceuical firm partners psychobiotic startup for first foray into microbiome modulation

Neuraxpharm Group, a pharmaceutical firm focused on the central nervous system (CNS), has announced its first foray in the probiotics catego

Bened powering through with expansion plans for proprietary ingredient

Bened Biomedical is moving ahead with its expansion plans, most recently signing a multi-year agreement for its proprietary psychobiotic PS1

Use your head, follow your gut: Bened Biomedical’s award-winning probiotic product set for market

The makers of a probiotic product targeting the gut-brain axis have highlighted research underlining how it can ease neurological conditions

Psychobiotic PS128™ Wins ‘Probiotic Product of the Year’ Award

The first NutraIngredients-Asia Awards have taken place in Singapore, with 10 winners crowned the region's nutrition and functional food sta